Results of two clinical trials on the safety and efficacy of pravastatin 80 and 160 mg per day
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (7) , 878-881
- https://doi.org/10.1016/s0002-9149(03)00026-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary HypercholesterolemiaCirculation, 2001
- Beneficial effects of pravastatin (±colestyramine/niacin) initiated immediately after a coronary event (the randomized lipid-coronary artery disease [L-CAD] study)The American Journal of Cardiology, 2000
- Increased Proinflammatory Cytokines in Patients With Chronic Stable Angina and Their Reduction By AspirinCirculation, 1999
- Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary SyndromesCirculation, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995